HFA Premium Access

About the speaker

Doctor Gal Aviel

Weizmann Institute of Science, Rehovot (Israel)
0 follower

4 more presentations in this session

FXa promotes endothelial dysfunction and pro-remodeling responses in atrial endothelial cells involving PAR1 and 2 and AT1R/NADPH oxidase/SGLT1/2 pro-oxidant pathways

Speaker: Ms W. Fakih (Illkirch Graffenstaden, FR)


Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.

Speaker: Ms A. Linders (Groningen, NL)


Living myocardial slices for the study of nucleic acid-based therapies

Speaker: Doctor R. Nunez-Toldra (London, GB)


Identification and characterization of small-molecule ERBB4 agonists as a treatment for heart failure

Speaker: Miss E. Feyen (Antwerp, BE)


Access the full session

New therapeutic approaches for heart failure

Speakers: Doctor G. Aviel, Ms W. Fakih, Ms A. Linders, Doctor R. Nunez-Toldra, Miss E. Feyen

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb